Abstract
Data published over the past decade show that Chlamydia pneumoniae is likely associated with the development of atherosclerosis. The aim of this study was to ascertain whether C. pneumoniae infections occur more frequently in patients with atherosclerosis than in healthy subjects. A total of 517 persons were studied. Serum samples, leukocytes, and tissue samples were assayed for the presence of C. pneumoniae-specific IgG and IgA antibodies and C. pneumoniae DNA. C. pneumoniae DNA was found in renal, iliac, and brachial vessels, but it was not detected in radial arteries. C. pneumoniae DNA was found most often in directional coronary atherectomy tissue specimens (11/41, 26.8%), but it was also found in the leukocytes of 14.9% (28/188) of patients with atherosclerosis and 24.6% (28/114) of patients without atheroma changes in vessels. Specific IgG and IgA antibodies were present in 63.8 and 49.9% of atheroma patients, respectively. The prevalence of C. pneumoniae antibodies differs significantly in patients with and without atherosclerosis (for IgG, p=0.002, and for IgA, p=0.006). The identification of persons with chlamydial infection of atherosclerotic arteries necessitates the examination of vascular tissues obtained during revascularization procedures. Serological investigation alone cannot identify individuals with vascular chlamydial infections. Detection of C. pneumoniae DNA in peripheral blood mononuclear cells does not seem to be the exclusive marker of persistent vascular infection. A more easily accessible parameter that allows prediction of chlamydial vascular infection is required.
Similar content being viewed by others
References
Siscovick DS, Schwartz SM, Caps M, Wang SP, Grayston JT (2000) Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology. J Infect Dis 181(Suppl 3):S417–S420
Berkow R, Fletcher AJ (1995) MSD manual of diagnosis and therapy. Urban & Partner, Wroclaw, p 462
Banach M, Markuszewski L, Zaslonka J, Grzegorczyk J, Okonski P, Jegier B (2004) The role of infection in the pathogenesis of atherosclerosis. Przegl Epidemiol 58:671–676
Mayr M, Kiechl S, Willeit J, Wick G, Xu Q (2000) Associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102:833–839
Stintzing S, Heuschmann P, Barbera L, Ocker M, Jung A, Kirchner T, Neureiter D (2005) Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation and apoptosis. Ann Vasc Surg 19:310–319
Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P (2003) Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108:678–683
Latsios G, Saetta A, Michalopoulos NV, Agapitos E, Patsouris E (2004) Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction. Acta Cardiol 59:652–657
Ossewaarde JM, Feskens EJM, Vries A, Vallinga CE, Kromhout DK (1998) Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 120:93–99
Ramirez JA, and the Chlamydia pneumoniae/Atherosclerosis Study Group (1996) Isolation of Chlamydia pneumoniae from the coronary artery of patient with coronary atherosclerosis. Ann Intern Med 125:979–982
Ramires JA, Higuchi MD (2002) Mycoplasma pneumoniae and Chlamydia pneumoniae are associated to inflammation and rupture of the atherosclerotic coronary plaques. Rev Esp Cardiol 55(Suppl 1):2–9
Saikku P, Leinonen M, Mattila K, Nieminen MS, Huttunen JK, Ekman MR, Makela PH, Valtonen V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infraction. Lancet ii:983–986
Danesh JP, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Chlamydia pneumoniae IgG titers and coronary heart disease: prospective study and meta-analysis. Br Med J 321:208–213
Grayston JT (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181(Suppl 3):S402–S410
Leinonen M (2000) Chlamydia pneumoniae and other risk factors for atherosclerosis. J Infect Dis 181(Suppl 3):S414–S416
Blasi F, Fagetti L, Allegra L (2000) Chlamydia pneumoniae detection in atherosclerotic plaques in Italy. J Infect Dis 181(Suppl 3):S444–S446
Jackson LA, Campbell LA, Kuo CC, Rodriquez DI, Lee A, Grayston JT (1997) Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 176:292–295
Kuo CC, Campbell LA (2000) Detection of Chlamydia pneumoniae in arterial tissue. J Infect Dis 181(Suppl 3):S432–S436
Maass M, Bartels SC, Engel PM, Momat U, Sievers HH (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31:827–832
Fong I (2000) Antibiotic effects in a rabbit model of Chlamydia pneumoniae—induced atherosclerosis. J Infect Dis 181(Suppl 3):514–518
Fong I, Chiu B, Viira E, Fong MW, Jang D, Mahony J (1997) Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 35:48–52
Moazed TC, Kuo CC, Grayston JT, Campbell LA (1997) Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 175:883–890
Airenne S, Surcel HM, Alakarppa H, Laitinen K, Saikku P, Laurila A (1996) Chlamydia pneumoniae infection in human monocytes. Infect Immun 67:1445–1449
Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614–1620
Moazed TC, Kuo CC, Grayston JT, Campbell LA (1998) Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 177:1322–1325
Yamaguchi H, Haranga S, Widen R, Friedman H, Yamamoto Y (2002) Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages. Infect Immun 70:2392–2398
Blasi F, Boman J, Esposito G, Melissano G, Chielsa R, Cosentini R, Tarsia P, Tshomba Y, Betti M, Alessi M, Morelli N, Allegra L (1999) Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis 180:2074–2076
Boman J, Gaydos CA (2000) Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis 181(Suppl 3):S452–S454
Boman J, Hammerschlag MR (2002) Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 15:1–20
Boman J, Soderberg S, Forsberg J, Birgander LS, Allard A, Persson K, Jidell E, Kumlin U, Juto P, Waldenstrom A, Wadell G (1998) High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178:274–277
Maass M, Jahn J, Gieffers J, Dalhoff K, Katus HA, Solbach W (2000) Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infraction. J Infect Dis 181(Suppl 3):S449–S451
Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, Morikawa T, Kawagoe K (1996) Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1. Evaluation of ELISA kit using outer membrane complex. Kansenshogaku Zasshi 70:821–829
Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, Numazaki K, Chiba S, Yamazaki T, Sasaki N, Kaku M, Shimanda J, Iwasaki E, Baba M, Koori Y, Aihara M, Chikumi H, Kosaba S, Nonaka Y, Ouchi K, Yamamoto T, Kashiwagi S, Kawayama T, Ohizumi K, Nagai H (1996) Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2: Studies on clinical usefulness and serological diagnostic standards. Kansenshogaku Zasshi 70:830–839
Tong CY, Sillis M (1993) Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 46:313–317
Campbell LA, O’Brien ER, Cappuccio AL, Kuo CC, Wang SP, Stewart DL, Patton PK, Cumming PK, Grayston JT (1995) Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 172:585–588
Shor A, Kuo CC, Patton DL (1992) Detection of Chlamydia pneumoniae in coronary artery fatty streaks and atheromatous plaques. S Afr Med J 82:158–161
Sessa R, Di Pietro M, Schiavoni G, Nicoletti M, Soda G, Nardoni S, Bosco D, Santino I, Cipriani P, Del Piano M (2004) Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries. Int J Immunopathol Pharmacol 17:301–306
Jantos CA, Nesseler A, Waas W, Baumgartner W, Tillmanns H, Haberbosh W (1999) Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease. Clin Infect Dis 28:988–992
Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J (1996) Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173:957–962
Paterson DL, Hall J, Rasmussen SJ, Timms P (1998) Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology 30:169–172
Apfalter P, Blasi F, Boman J, Gaydos CA, Kundi M, Maass M, Makristathis A, Meijer A, Nadrchal R, Persson K, Rotter ML, Tong CYW, Stanek G, Hirschl AM (2001) Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endartectomy specimens. J Clin Microbiol 39:519–524
Gieffers J, van Zandbergen G, Rupp J, Sayk F, Kruger S, Ehlers S, Solbach W, Maass M (2004) Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur Respir J 23:506–510
Gieffers J, Fullgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, Solbach W, Maass M (2001) Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103:351–356
Pantoja LG, Miller RD, Ramirez JA, Molestina RE, Summersgill JT (2000) Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by γ interferon-induced indoleamine 2,3-dioxygenase activity. Infect Immun 68:6478–6481
Gieffers J, Durling L, Ouellette SP, Rupp J, Maass M, Byrne GI, Caldwell HD, Belland RJ (2003) Genotypic differences in the Chlamydia pneumoniae tyrP locus related to vascular tropism and pathogenicity. J Infect Dis 188:1085–1093
Cochrane M, Pospischil A, Walker P, Gibbs H, Timms P (2005) Discordant detection of Chlamydia pneumoniae in patients with carotid artery disease using polymerase chain reaction, immunofluorescence microscopy and serological methods. Pathology 37:69–75
Freidank HM, Billing H, Wiedmann-Al-Ahmad M (2001) Influence of iron restriction on Chlamydia pneumoniae and C trachomatis. J Med Microbiol 50:223–227
Karvonen M, Tuomilehto J, Pitkaniemi J, Naukkarinen A, Saikku P (1994) Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 23:1315–1321
Acknowledgement
This study was supported by the research funds from the State Committee for Scientific Research, 4PO5D 038 17.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Podsiadły, E., Przyłuski, J., Kwiatkowski, A. et al. Presence of Chlamydia pneumoniae in patients with and without atherosclerosis. Eur J Clin Microbiol Infect Dis 24, 507–513 (2005). https://doi.org/10.1007/s10096-005-1380-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-005-1380-0